(Q77304849)
Statements
Treatment with interleukin-2 (IL-2) and interferon (IFN(alpha 2b)) after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse (English)
P Vivancos
A Grañena
J Sarrá